corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 14721

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Bubela T, Boon H, Caulfield T.
Herbal remedy clinical trials in the media: a comparison with the coverage of conventional pharmaceuticals.
BMC Med 2008 Nov 26; 6:(1):35
http://www.biomedcentral.com/1741-7015/6/35/abstract


Abstract:

ABSTRACT: BACKGROUND: This study systematically compares newspaper coverage of clinical trials for herbal remedies, a popular type of complementary and alternative medicine (CAM), with clinical trials for pharmaceuticals using a comparative content analysis. This is a timely inquiry given the recognized importance of the popular press as a source of health information, the complex and significant role of CAM in individual health care decisions, and the trend toward evidence based research for some CAM therapies. METHODS: We searched PubMed for clinical trials, Lexis/Nexis for newspaper articles in the UK, US, Australia/NZ, and Factiva for Canadian newspaper articles from 1995-2005. We used a coding frame to analyse and compare 48 pharmaceutical and 57 herbal remedy clinical trials as well as 201 pharmaceutical and 352 herbal remedy newspaper articles. RESULTS: Herbal remedy clinical trials had similar Jadad scores to pharmaceutical trials but were significantly smaller and of shorter duration. The trials were mostly studies from western countries and published in high-ranking journals. The majority of pharmaceutical (64%) and herbal remedy (53%) clinical trials had private sector funding involvement. The minority declared further author conflicts of interest. Newspaper coverage of herbal remedy clinical trials was more negative than for pharmaceutical trials; a result only partly explained by the greater proportion of herbal remedy clinical trials reporting negative results (p=0.0201; chi2 = 7.8129; DF = 2). Errors of omission were common in newspaper coverage, with little reporting of dose, sample size, location and duration of the trial, methods, trial funding and conflicts of interest. There was an under-reporting of risks, especially for herbal remedies. CONCLUSIONS: Our finding of negative coverage of herbal remedy trials is contrary to the positive trends in most published research based primarily on anecdotal accounts. Our results highlight how media coverage is not providing the public with the information necessary to make informed decisions about medical treatments. Most concerning is the lack of disclosure of trial funding and conflicts of interest that could influence the outcome or reporting of trial results. This lack of reporting may impact the medical research community who have the most to lose by way of public trust and respect.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








As an advertising man, I can assure you that advertising which does not work does not continue to run. If experience did not show beyond doubt that the great majority of doctors are splendidly responsive to current [prescription drug] advertising, new techniques would be devised in short order. And if, indeed, candor, accuracy, scientific completeness, and a permanent ban on cartoons came to be essential for the successful promotion of [prescription] drugs, advertising would have no choice but to comply.
- Pierre R. Garai (advertising executive) 1963